Authors: Morr, H

Citation: H. Morr, Respiratory distress syndrome - Epidemiology, economic significance and care structures in the case of chronic obstructive pulmonary disease, INTERNIST, 42(3), 2001, pp. 373

Authors: Schneider, J Morr, H Velcovsky, HG Weisse, G Eigenbrodt, E

Citation: J. Schneider et al., Quantitative detection of Tumor M2-pyruvate kinase in plasma of patients with lung cancer in comparison to other lung diseases, CANCER DET, 24(6), 2000, pp. 531-535

Authors: Gunther, A Mosavi, P Ruppert, C Heinemann, S Temmesfeld, B Velcovsky, HG Morr, H Grimminger, F Walmrath, D Seeger, W

Citation: A. Gunther et al., Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease, THROMB HAEM, 83(6), 2000, pp. 853-860

Authors: Schneider, J Velcovsky, HG Morr, H Katz, N Neu, K Eigenbrodt, E

Citation: J. Schneider et al., Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer, ANTICANC R, 20(6D), 2000, pp. 5053-5058

Authors: Gunther, A Schmidt, R Nix, F Yabut-Perez, M Guth, C Rosseau, S Siebert, C Grimminger, F Morr, H Velcovsky, HG Seeger, W

Citation: A. Gunther et al., Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis, EUR RESP J, 14(3), 1999, pp. 565-573

Authors: Lohmeyer, J Friedrich, J Grimminger, F Maus, U Tenter, R Morr, H Velcovsky, HG Seeger, W Rosseau, S

Citation: J. Lohmeyer et al., Expression of mucosa-related integrin alpha(E)beta(7) on alveolar T cells in interstitial lung diseases, CLIN EXP IM, 116(2), 1999, pp. 340-346